80 results
8-K
GH
Guardant Health Inc
8 Jan 24
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results
4:17pm
.
Item 7.01.
Regulation FD Disclosure.
The Company will post the presentation that it will present at the 2024 J.P. Morgan Healthcare Conference
8-K
EX-99.1
GH
Guardant Health Inc
15 Nov 23
Other Events
6:04am
analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare
8-K
EX-99.1
cvncv69i 9q0qcoo1
6 Nov 23
Guardant Health Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
4:10pm
8-K
EX-99.1
cm383tv7i0r4qefqimm
3 Aug 23
Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance
4:14pm
8-K
EX-99.1
uqe9x5 jml8
1 Aug 23
Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research
4:15pm
8-K
EX-99.1
7sm3zru 7routpoc7reg
9 May 23
Guardant Health Reports First Quarter 2023 Financial Results
4:13pm
8-K
EX-99.1
ia03wl5hriesj53gq
9 May 23
Guardant Health presents additional information from ECLIPSE study at 2023 Digestive Disease Week on the performance of Shield™ blood test
10:23am
8-K
EX-99.1
swjjiy8v c42j
8 May 23
Guardant Health Announces Additions to Leadership Team
4:29pm
8-K
e15mkohd u2ga
8 May 23
Guardant Health Announces Additions to Leadership Team
4:29pm
8-K
EX-99.1
zdc66n4wcqm
15 Dec 22
Guardant Health announces positive results from pivotal ECLIPSE study evaluating a blood test for the detection of colorectal cancer
4:17pm
8-K
EX-99.1
uix8ck3s
3 Nov 22
Guardant Health Reports Third Quarter 2022 Financial Results
4:11pm